Commissioner Nominee Hamburg Questioned On FDA’s Role In Health Reform
Executive Summary
Congressional questioning during the confirmation hearing of FDA Commissioner-designate Margaret Hamburg May 7 underscored the influence the probable agency chief would have in an era of health care reform
You may also be interested in...
Conspicuous Consumption: TB Therapies Are A Priority At FDA
A June 3 advisory committee discussion of tuberculosis drug development offers a good early case study of how the Hamburg FDA may benefit some classes of drug development
Conspicuous Consumption: TB Therapies Are A Priority At FDA
A June 3 advisory committee discussion of tuberculosis drug development offers a good early case study of how the Hamburg FDA may benefit some classes of drug development
Opening Product Labeling To Broader CE Data Is Proposed In Senate Bill
Drug product labels could contain an array of comparative effectiveness data beyond well-controlled clinical trials, if Sens. Jack Reed, D-R.I., and Barbara Mikulski, D-Md., get their way